Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2020 Aug;190(4):e192-e195.
doi: 10.1111/bjh.16968. Epub 2020 Jul 19.

COVID-19 mortality in patients on anticoagulants and antiplatelet agents

Helena Sivaloganathan  1   2 , Eleni E Ladikou  1   2 , Timothy Chevassut  1   2
Affiliations
Randomized Controlled Trial

COVID-19 mortality in patients on anticoagulants and antiplatelet agents

Helena Sivaloganathan et al. Br J Haematol. 2020 Aug.
No abstract available

Keywords: COVID-19; anticoagulants; antiplatelets; mortality; thrombosis; thrombosis (venous).

PubMed Disclaimer

Conflict of interest statement

No conflict of interest relevant to this letter was identified.

Figures

Fig 1
Fig 1
Kaplan–Meier plots of inpatients with COVID‐19 who were on (A) anticoagulation before admission versus those who were not and (B) antiplatelets before admission versus those who were not.
Fig 2
Fig 2
Kaplan–Meier plots of inpatients with COVID‐19 according to their (A) anticoagulant before admission and (B) antiplatelet before admission. DOAC, direct oral anticoagulants.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020;18:844–7. - PMC - PubMed
    1. Al‐Samkari H, Karp Leaf R, Dzik W, Carlson J, Fogerty A, Waheed A, et al. COVID and coagulation: bleeding and thrombotic manifestations of SARS‐CoV2 infection. Blood. 2020. [Online ahead of print]. 10.1182/blood.2020006520. - DOI - PMC - PubMed
    1. Zhang T, Sun LX, Feng RE. [Comparison of clinical and pathological features between severe acute respiratory syndrome and coronavirus disease 2019] [Article in Chinese]. Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:496–502. - PubMed
    1. Songping C, Shuo C, Xiunan L, Shi L, Feng W. Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia. J Thromb Haemost. 2020;18(6):1421–1424. - PMC - PubMed
    1. Klok F, Kruip M, van der Meer N, Arbous M, Gommers D, Kant K, et al. Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID‐19: an updated analysis. Thromb Res. 2020;19:148–50. - PMC - PubMed

Substances